Gentex Corporation Announces Agreements With New Partners for Ops-Core
CARBONDALE, Pa.--(BUSINESS WIRE)--Gentex Corporation, a global leader in personal protection and situational awareness solutions for defense forces, emergency responders and industrial personnel, has announced partnerships with new development collaborators as part of its Ops-Core RAILINK system accessory program. MOHOC, Inc., Advanced Material and Devices (AMAD), NanoAi Technologies and seven additional partners have entered royalty-free license agreements to create new accessories, further expanding the RAILINK ecosystem and enhancing its capabilities for end users.
These agreements with new development partners underscore Gentex's commitment to continuing to expand and evolve the capabilities of this innovative platform.
Share
'These agreements with new development partners underscore Gentex's commitment to continuing to expand and evolve the capabilities of this innovative platform. By leveraging the expertise of industry leaders in their respective capability domains to develop more accessories, we continue to push the boundaries of what's possible for our end users, and the system becomes more impactful to a broader audience,' said Rafe Bennett, Vice President of Product Management at Gentex Corporation.
To support future product and accessory development, Gentex offers select industry partners royalty-free licensing and optional technical assistance, simplifying the process of leveraging the patented RAILINK system's advanced capabilities. To learn more about becoming a RAILINK Development Partner and sign up for future RAILINK announcements click https://www.gentexcorp.com/introducing-railink/
About RAILINK Power and Data System
The RAILINK platform facilitates integration of a broad range of sensors, displays, augmented reality capability and wireless functionality on the headborne system. Powered by a central helmet power center, feeding power to, and sharing data between, an array of smart nodes and a VAS/NVG interface RAILINK improves protection and lethality by increasing the effectiveness of the user and reducing their burden.
About MOHOC, Inc.
Founded in 2014, MOHOC develops specialized cameras for elite end users. MOHOC products serve the Special Forces, defense, tactical law enforcement and first responders in the US and over 70 countries worldwide with both video recording cameras and the new MOHOC ® 2 series for live video streaming. For further information, please visit www.mohoc.com.
About Advanced Material and Devices
AMAD develops next-generation blast sensor products for air, underwater and human surrogate applications, supporting its vision to innovate systems that enhance the safety and protection of personnel and equipment. AMAD's expertise also extends into magnetorheological (MR) materials and devices, providing adaptive solutions for protective systems. Learn more about AMAD here.
About NanoAi Technologies
NanoAi Technologies is a proven proprietary platform sensing technology with the ability to detect explosives, ammunition and narcotics at standoff distances with wearable, drone/robot/vehicle and mounted capabilities. Combined with the full force of its artificial intelligence, swarming capabilities and geolocation of each sensor providing immediate real-time results simultaneously to operators in the field and the task force. For more on NanoAi, visit www.nanoaitechnology.com
About Gentex Corporation
Part of Gentex Corporation's portfolio for defense, emergency response and security forces, the focus and dedication of the company's Ops-Core brand remains the same – protecting elite forces. The modular, scalable, open-architecture design of Ops-Core products allows for seamless integration and true system level performance.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
4 hours ago
- Business Wire
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (' Innate ' or the ' Company ') today announced that members of its executive team will participate in the upcoming investor conferences, detailed below. H.C. Wainwright 3 rd Annual Immune Cell Engager Virtual Conference Dates: June 24, 2025 | Virtual Wolfe Research Virtual Biotech Day Dates: June 26, 2025 | Virtual About Innate Pharma Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through three therapeutic approaches: multi-specific NK Cell Engagers via its ANKET ® (A ntibody-based NK cell E ngager T herapeutics) proprietary platform and Antibody Drug Conjugates (ADC) and monoclonal antibodies (mAbs). Innate's portfolio includes several ANKET ® drug candidates to address multiple tumor types as well as IPH4502, a differentiated ADC in development in solid tumors. In addition, anti-KIR3DL2 mAb lacutamab is developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, and anti-NKG2A mAb monalizumab is developed with AstraZeneca in non-small cell lung cancer. Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients. Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US. Learn more about Innate Pharma at and follow us on LinkedIn and X. Information about Innate Pharma shares Disclaimer on forward-looking information and risk factors This press release contains certain forward-looking statements, including those within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995. The use of certain words, including 'anticipate,' 'believe,' 'can,' 'could,' 'estimate,' 'expect,' 'may,' 'might,' 'potential,' 'intend,' 'should,' 'will,' or the negative of these and similar expressions, is intended to identify forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company's reliance on third parties to manufacture its product candidates, the Company's commercialization efforts and the Company's continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties, which could cause the Company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors ('Facteurs de Risque") section of the Universal Registration Document filed with the French Financial Markets Authority ('AMF'), which is available on the AMF website or on Innate Pharma's website, and public filings and reports filed with the U.S. Securities and Exchange Commission ('SEC'), including the Company's Annual Report on Form 20-F for the year ended December 31, 2024, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public by the Company. References to the Company's website and the AMF website are included for information only and the content contained therein, or that can be accessed through them, are not incorporated by reference into, and do not constitute a part of, this press release. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.
Business Wire
11 hours ago
- Business Wire
Gentex Corporation Announces Agreements With New Partners for Ops-Core
CARBONDALE, Pa.--(BUSINESS WIRE)--Gentex Corporation, a global leader in personal protection and situational awareness solutions for defense forces, emergency responders and industrial personnel, has announced partnerships with new development collaborators as part of its Ops-Core RAILINK system accessory program. MOHOC, Inc., Advanced Material and Devices (AMAD), NanoAi Technologies and seven additional partners have entered royalty-free license agreements to create new accessories, further expanding the RAILINK ecosystem and enhancing its capabilities for end users. These agreements with new development partners underscore Gentex's commitment to continuing to expand and evolve the capabilities of this innovative platform. Share 'These agreements with new development partners underscore Gentex's commitment to continuing to expand and evolve the capabilities of this innovative platform. By leveraging the expertise of industry leaders in their respective capability domains to develop more accessories, we continue to push the boundaries of what's possible for our end users, and the system becomes more impactful to a broader audience,' said Rafe Bennett, Vice President of Product Management at Gentex Corporation. To support future product and accessory development, Gentex offers select industry partners royalty-free licensing and optional technical assistance, simplifying the process of leveraging the patented RAILINK system's advanced capabilities. To learn more about becoming a RAILINK Development Partner and sign up for future RAILINK announcements click About RAILINK Power and Data System The RAILINK platform facilitates integration of a broad range of sensors, displays, augmented reality capability and wireless functionality on the headborne system. Powered by a central helmet power center, feeding power to, and sharing data between, an array of smart nodes and a VAS/NVG interface RAILINK improves protection and lethality by increasing the effectiveness of the user and reducing their burden. About MOHOC, Inc. Founded in 2014, MOHOC develops specialized cameras for elite end users. MOHOC products serve the Special Forces, defense, tactical law enforcement and first responders in the US and over 70 countries worldwide with both video recording cameras and the new MOHOC ® 2 series for live video streaming. For further information, please visit About Advanced Material and Devices AMAD develops next-generation blast sensor products for air, underwater and human surrogate applications, supporting its vision to innovate systems that enhance the safety and protection of personnel and equipment. AMAD's expertise also extends into magnetorheological (MR) materials and devices, providing adaptive solutions for protective systems. Learn more about AMAD here. About NanoAi Technologies NanoAi Technologies is a proven proprietary platform sensing technology with the ability to detect explosives, ammunition and narcotics at standoff distances with wearable, drone/robot/vehicle and mounted capabilities. Combined with the full force of its artificial intelligence, swarming capabilities and geolocation of each sensor providing immediate real-time results simultaneously to operators in the field and the task force. For more on NanoAi, visit About Gentex Corporation Part of Gentex Corporation's portfolio for defense, emergency response and security forces, the focus and dedication of the company's Ops-Core brand remains the same – protecting elite forces. The modular, scalable, open-architecture design of Ops-Core products allows for seamless integration and true system level performance.
Yahoo
12 hours ago
- Yahoo
Serve Robotics CEO Ali Kashani Named EY Entrepreneur Of The Year® 2025 Bay Area Award Winner
SAN FRANCISCO, June 16, 2025 (GLOBE NEWSWIRE) -- Serve Robotics (the "Company" or "Serve") (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today announced that Co-Founder and CEO Dr. Ali Kashani has been named a 2025 Entrepreneur Of The Year® Bay Area Award Winner by Ernst & Young LLP (EY US).This prestigious award, now in its 40th year, honors entrepreneurs and leaders of high-growth companies who are building and scaling successful, innovative businesses. Dr. Kashani was selected by an independent panel of judges including past winners, top CEOs and other business luminaries. Judges assessed candidates on entrepreneurial spirit, purpose-driven commitment, long-term value creation and company growth and impact. Dr. Kashani is now eligible for the Entrepreneur of the Year 2025 National Awards, to be presented at the EY Strategic Growth Forum® in November. 'I'm deeply honored to receive an award that celebrates the entrepreneurial journey,' said Dr. Kashani. 'This recognition is only possible because of the incredible team of makers and dreamers who've worked tirelessly alongside me to build Serve into the enterprise it is today.' Dr. Kashani's entrepreneurial journey began with a vision to make delivery more sustainable, economical and accessible through robotics. In 2017, he founded what would become Serve Robotics as a skunkworks robotics initiative within Postmates. Following Uber's acquisition of Postmates, Dr. Kashani led the spinout of Serve as an independent company in 2021. Under his leadership, Serve has grown from an internal startup to a publicly traded company, completing tens of thousands of commercial deliveries in major U.S. cities including Los Angeles, Miami, Dallas and Atlanta. About Serve RoboticsServe Robotics develops advanced, AI-powered, low-emissions sidewalk delivery robots that endeavor to make delivery sustainable and economical. Spun off from Uber in 2021 as an independent company, Serve has completed tens of thousands of deliveries for enterprise partners such as Uber Eats and 7-Eleven. Serve has scalable multi-year contracts, including a signed agreement to deploy up to 2,000 delivery robots on the Uber Eats platform across multiple U.S. markets. For further information about Serve Robotics (Nasdaq: SERV), please visit or follow us on social media via X (Twitter), Instagram or LinkedIn @serverobotics. About EYEY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams work across a full spectrum of services in assurance, consulting, tax, strategy and transactions. Fueled by sector insights, a globally connected, multi-disciplinary network and diverse ecosystem partners, EY teams can provide services in more than 150 countries and territories. All in to shape the future with confidence. EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ContactsMediaAduke ThelwellHead of Communications & Investor Relationspress@ Investor A photo accompanying this announcement is available at in to access your portfolio
